Medtronic Stops Distribution and Sale of HeartWare HVAD System Due to Risk of Neurological Adverse Events, Mortality, and Potential Failure to Restart

Increased risk of neurological adverse events, mortality and possible failure of the pump to restart led to stop sale and distribution of HeartWare HVAD System

Original source:

Related Posts